• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The production and biological distribution of yttrium-90 labelled antibodies.

作者信息

Vaughan A T, Keeling A, Yankuba S C

出版信息

Int J Appl Radiat Isot. 1985 Oct;36(10):803-6. doi: 10.1016/0020-708x(85)90031-6.

DOI:10.1016/0020-708x(85)90031-6
PMID:4055089
Abstract

An antibody has been labelled with generator produced yttrium-90 (90Y) via a chelating group (DTPA) covalently attached to the protein. An average yield for protein labelling of 76% was obtained. The blood clearance of iodinated and 90Y labelled antibody is similar in rats and mice. However, in contrast to iodine, the yttrium label accumulates in the liver after release from the protein.

摘要

相似文献

1
The production and biological distribution of yttrium-90 labelled antibodies.
Int J Appl Radiat Isot. 1985 Oct;36(10):803-6. doi: 10.1016/0020-708x(85)90031-6.
2
Generator-produced yttrium-90 for radioimmunotherapy.用于放射免疫治疗的发生器产生的钇-90。
J Nucl Med. 1987 Sep;28(9):1465-70.
3
90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.90Y-多胺基多羧基大环配体-人源化抗CD19单克隆抗体：一种用于非霍奇金淋巴瘤放射免疫治疗的药物。
J Nucl Med. 2003 Jan;44(1):77-84.
4
Synthesis, characterisation, and biodistribution of radioiodinated C-hydroxy-carboranes.放射性碘标记 C-羟基卡硼烷的合成、表征及生物分布。
Chemistry. 2012 Aug 27;18(35):11071-8. doi: 10.1002/chem.201200833. Epub 2012 Jul 16.
5
DTPA-coupled antibodies labeled with yttrium-90.用钇-90标记的二乙三胺五乙酸偶联抗体。
J Nucl Med. 1985 May;26(5):503-9.
6
Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.与内化抗体偶联时，俄歇电子发射放射性金属或放射性碘相比，俄歇电子发射体的治疗优势。
Eur J Nucl Med. 2000 Jul;27(7):753-65. doi: 10.1007/s002590000272.
7
90Y-labeled antibody uptake by human tumor xenografts and the effect of systemic administration of EDTA.
Int J Radiat Oncol Biol Phys. 1994 Mar 30;28(5):1257-65. doi: 10.1016/0360-3016(94)90503-7.
8
Intraperitoneal 131I- and 90Y-labelled monoclonal antibodies for ovarian cancer: pharmacokinetics and normal tissue dosimetry.用于卵巢癌的腹腔内131I和90Y标记单克隆抗体：药代动力学和正常组织剂量测定
Int J Cancer Suppl. 1988;3:71-6.
9
The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates.
Int J Rad Appl Instrum B. 1991;18(5):469-76. doi: 10.1016/0883-2897(91)90107-v.
10
Labelling monoclonal antibodies with yttrium-90.
Eur J Nucl Med. 1989;15(6):307-12. doi: 10.1007/BF00435471.

引用本文的文献

1
Sorption Characteristics and Chromatographic Separation of Y from Sr from Aqueous Media by Chelex-100 (Anion Ion Exchange) Packed Column.通过Chelex-100（阴离子交换）填充柱从水介质中吸附Y和Sr的特性及色谱分离
Int J Anal Chem. 2024 May 13;2024:6232381. doi: 10.1155/2024/6232381. eCollection 2024.
2
Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer.用于癌症诊断和治疗的抗体放射性标记方法。
Pharm Res. 1988 Jun;5(6):325-34. doi: 10.1023/a:1015995208444.
3
Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias.
钇-90-乙二胺四甲撑膦酸：一种用于治疗白血病的放射治疗剂。
Br J Cancer. 1989 Jul;60(1):74-8. doi: 10.1038/bjc.1989.223.
4
Labelling monoclonal antibodies with yttrium-90.
Eur J Nucl Med. 1989;15(6):307-12. doi: 10.1007/BF00435471.
5
Macrocyclic chelates of radiometals for diagnosis and therapy.用于诊断和治疗的放射性金属大环螯合物。
Br J Cancer Suppl. 1990 Jul;10:21-6.